These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 27789378)
1. Whole genome sequencing for M/XDR tuberculosis surveillance and for resistance testing. Walker TM; Merker M; Kohl TA; Crook DW; Niemann S; Peto TE Clin Microbiol Infect; 2017 Mar; 23(3):161-166. PubMed ID: 27789378 [TBL] [Abstract][Full Text] [Related]
2. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China. Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458 [TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis. Sougakoff W Clin Microbiol Infect; 2011 Jun; 17(6):800-5. PubMed ID: 21682800 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis. Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491 [TBL] [Abstract][Full Text] [Related]
5. Personalizing therapy for multidrug resistant TB: the potential of Rapid Whole Genome Sequencing. Bryant JM; Lipman M; Breuer J Expert Rev Anti Infect Ther; 2016; 14(1):1-3. PubMed ID: 26559223 [TBL] [Abstract][Full Text] [Related]
7. Clinical use of whole genome sequencing for Mycobacterium tuberculosis. Witney AA; Cosgrove CA; Arnold A; Hinds J; Stoker NG; Butcher PD BMC Med; 2016 Mar; 14():46. PubMed ID: 27004841 [TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective. Perdigão J; Macedo R; João I; Fernandes E; Brum L; Portugal I Microb Drug Resist; 2008 Jun; 14(2):133-43. PubMed ID: 18573039 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China. Zhou A; Nawaz M; Duan Y; Moore JE; Millar BC; Xu J; Yao Y Microb Drug Resist; 2011 Jun; 17(2):275-81. PubMed ID: 21388297 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012. Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471 [TBL] [Abstract][Full Text] [Related]
11. Molecular snapshot of Mycobacterium tuberculosis population structure and drug-resistance in Kyrgyzstan. Mokrousov I; Isakova J; Valcheva V; Aldashev A; Rastogi N Tuberculosis (Edinb); 2013 Sep; 93(5):501-7. PubMed ID: 23890973 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation of isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Central Tunisia. Ben Kahla I; Marzouk M; Henry M; Bedotto M; Cohen-Bacrie S; Ben Selma W; Boukadida J; Drancourt M Int J Tuberc Lung Dis; 2011 Dec; 15(12):1685-8. PubMed ID: 22118179 [TBL] [Abstract][Full Text] [Related]
13. Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania. Bang D; Andersen SR; Vasiliauskienė E; Rasmussen EM Diagn Microbiol Infect Dis; 2016 Dec; 86(4):377-381. PubMed ID: 27641092 [TBL] [Abstract][Full Text] [Related]
14. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs. Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034 [TBL] [Abstract][Full Text] [Related]
15. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis]. Rueda J; Realpe T; Mejía G; Zapata E; Robledo J Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443 [TBL] [Abstract][Full Text] [Related]
16. Acquisition of second-line drug resistance and extensive drug resistance during recent transmission of Mycobacterium tuberculosis in rural China. Hu Y; Mathema B; Zhao Q; Chen L; Lu W; Wang W; Kreiswirth B; Xu B Clin Microbiol Infect; 2015 Dec; 21(12):1093.e9-1093.e18. PubMed ID: 26348262 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of mutations at codon 463 of katG gene in MDR and XDR clinical isolates of Mycobacterium tuberculosis in Belarus and application of the method in rapid diagnosis. Arjomandzadegan M; Owlia P; Ranjbar R; Farazi AA; Sofian M; Sadrnia M; Ghaznavi-Rad E; Surkova LK; Titov LP Acta Microbiol Immunol Hung; 2011 Mar; 58(1):51-63. PubMed ID: 21450555 [TBL] [Abstract][Full Text] [Related]
18. TGS-TB: Total Genotyping Solution for Mycobacterium tuberculosis Using Short-Read Whole-Genome Sequencing. Sekizuka T; Yamashita A; Murase Y; Iwamoto T; Mitarai S; Kato S; Kuroda M PLoS One; 2015; 10(11):e0142951. PubMed ID: 26565975 [TBL] [Abstract][Full Text] [Related]
19. Whole genome analysis of an MDR Beijing/W strain of Mycobacterium tuberculosis with large genomic deletions associated with resistance to isoniazid. Zhang Q; Wan B; Zhou A; Ni J; Xu Z; Li S; Tao J; Yao Y Gene; 2016 May; 582(2):128-36. PubMed ID: 26854371 [TBL] [Abstract][Full Text] [Related]
20. [Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China]. Wang JJ; Hu Y; Jiang WL; Wang WB; Xu B Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1189-93. PubMed ID: 20193593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]